Adam A. Filipczyk

  • Project group leader; Ph.D.
  • +47 23 07 40 68
 

Publications 2021

Jin KX, Zuo R, Anastassiadis K, Klungland A, Marr C, Filipczyk A (2021)
N6-methyladenosine (m6A) depletion regulates pluripotency exit by activating signaling pathways in embryonic stem cells
Proc Natl Acad Sci U S A, 118 (51)
DOI 10.1073/pnas.2105192118, PubMed 34921114

Publications 2016

Feigelman J, Ganscha S, Hastreiter S, Schwarzfischer M, Filipczyk A, Schroeder T, Theis FJ, Marr C, Claassen M (2016)
Analysis of Cell Lineage Trees by Exact Bayesian Inference Identifies Negative Autoregulation of Nanog in Mouse Embryonic Stem Cells
Cell Syst, 3 (5), 480-490.e13
DOI 10.1016/j.cels.2016.11.001, PubMed 27883891

Hilsenbeck O, Schwarzfischer M, Skylaki S, Schauberger B, Hoppe PS, Loeffler D, Kokkaliaris KD, Hastreiter S, Skylaki E, Filipczyk A, Strasser M, Buggenthin F, Feigelman JS, Krumsiek J, van den Berg AJ, Endele M, Etzrodt M, Marr C, Theis FJ, Schroeder T (2016)
Software tools for single-cell tracking and quantification of cellular and molecular properties
Nat Biotechnol, 34 (7), 703-6
DOI 10.1038/nbt.3626, PubMed 27404877

Hoppe PS, Schwarzfischer M, Loeffler D, Kokkaliaris KD, Hilsenbeck O, Moritz N, Endele M, Filipczyk A, Gambardella A, Ahmed N, Etzrodt M, Coutu DL, Rieger MA, Marr C, Strasser MK, Schauberger B, Burtscher I, Ermakova O, Bürger A, Lickert H, Nerlov C, Theis FJ, Schroeder T (2016)
Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios
Nature, 535 (7611), 299-302
DOI 10.1038/nature18320, PubMed 27411635

Klungland A, Dahl JA, Greggains G, Fedorcsak P, Filipczyk A (2016)
Reversible RNA modifications in meiosis and pluripotency
Nat Methods, 14 (1), 18-22
DOI 10.1038/nmeth.4111, PubMed 28032624

Publications 2015

Filipczyk A, Marr C, Hastreiter S, Feigelman J, Schwarzfischer M, Hoppe PS, Loeffler D, Kokkaliaris KD, Endele M, Schauberger B, Hilsenbeck O, Skylaki S, Hasenauer J, Anastassiadis K, Theis FJ, Schroeder T (2015)
Network plasticity of pluripotency transcription factors in embryonic stem cells
Nat Cell Biol, 17 (10), 1235-46
DOI 10.1038/ncb3237, PubMed 26389663

Publications 2013

Filipczyk A, Gkatzis K, Fu J, Hoppe PS, Lickert H, Anastassiadis K, Schroeder T (2013)
Biallelic expression of nanog protein in mouse embryonic stem cells
Cell Stem Cell, 13 (1), 12-3
DOI 10.1016/j.stem.2013.04.025, PubMed 23827706

Publications 2011

Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, Filipczyk AA, Halle S, Klump H, Schöler HR, Baum C, Schroeder T, Schambach A (2011)
Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming
Mol Ther, 19 (4), 782-9
DOI 10.1038/mt.2010.314, PubMed 21285961

Publications 2007

Filipczyk AA, Laslett AL, Mummery C, Pera MF (2007)
Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells
Stem Cell Res, 1 (1), 45-60
DOI 10.1016/j.scr.2007.09.002, PubMed 19383386

Filipczyk AA, Passier R, Rochat A, Mummery CL (2007)
Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling
Cell Mol Life Sci, 64 (6), 704-18
DOI 10.1007/s00018-007-6523-2, PubMed 17380311

Publications 2006

Herszfeld D, Wolvetang E, Langton-Bunker E, Chung TL, Filipczyk AA, Houssami S, Jamshidi P, Koh K, Laslett AL, Michalska A, Nguyen L, Reubinoff BE, Tellis I, Auerbach JM, Ording CJ, Looijenga LH, Pera MF (2006)
CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells
Nat Biotechnol, 24 (3), 351-7
DOI 10.1038/nbt1197, PubMed 16501577

Page visits: 7455